2002 Bipolar disorder Pharmaceuticals 
Mad in America
JANUARY 9, 2024
Academics even boast that EBM shackles the pharmaceutical industry. In 2002, applying to the FDA to license Paxil as an antidepressant for children, GSK submitted 3 assays, one being Study 329, stating all 3 were negative. Doctors adamantly insist they are not influenced by adverts. They go by the evidence.
Mad in America
OCTOBER 21, 2023
Thomas Insel, director of the National Institute of Mental Health (NIMH) from 2002-2015, acknowledged in 2011, “Whatever we’ve been doing for five decades, it ain’t working. The psychiatric-pharmaceutical-industrial complex is fueled by the profits of Big Pharma, which have made a staggering amount of money from psychiatric drugs.
Expert insights. Personalized for you.
136 
Let's personalize your content